204 related articles for article (PubMed ID: 16978811)
1. Conformational polymorphism in bicalutamide.
Vega DR; Polla G; Martinez A; Mendioroz E; Reinoso M
Int J Pharm; 2007 Jan; 328(2):112-8. PubMed ID: 16978811
[TBL] [Abstract][Full Text] [Related]
2. Polymorph transitions of bicalutamide: a remarkable example of mechanical activation.
Német Z; Sztatisz J; Demeter A
J Pharm Sci; 2008 Aug; 97(8):3222-32. PubMed ID: 18085711
[TBL] [Abstract][Full Text] [Related]
3. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
4. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
Li C; Li C; Le Y; Chen JF
Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
[TBL] [Abstract][Full Text] [Related]
5. Nanosized bicalutamide and its molecular structure in solvents.
Le Y; Ji H; Chen JF; Shen Z; Yun J; Pu M
Int J Pharm; 2009 Mar; 370(1-2):175-80. PubMed ID: 19101616
[TBL] [Abstract][Full Text] [Related]
6. Solid-state characterization of falicaine hydrochloride and isomorphic dyclonine hydrochloride. Part IV. Crystal polymorphism of local anaesthetic drugs.
Schmidt AC
Eur J Pharm Sci; 2005; 25(4-5):407-16. PubMed ID: 15896948
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the Dissolution Mechanisms of Amorphous Bicalutamide Solid Dispersions via Real-Time Raman Mapping.
Tres F; Patient JD; Williams PM; Treacher K; Booth J; Hughes LP; Wren SA; Aylott JW; Burley JC
Mol Pharm; 2015 May; 12(5):1512-22. PubMed ID: 25872658
[TBL] [Abstract][Full Text] [Related]
8. Planetary ball milling and supercritical fluid technology as a way to enhance dissolution of bicalutamide.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Kurek M; Syrek K; Chmiel K; Paluch M; Jachowicz R
Int J Pharm; 2017 Nov; 533(2):470-479. PubMed ID: 28363855
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism and H-bonding of 2-[1(2H)-oxo-2-phthalazinyl]methylbenzoic acid.
Ferrari P; Nebuloni M; Pelizza G; Gallo GG
Farmaco Sci; 1977 Aug; 32(8):560-9. PubMed ID: 891910
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism of 1-methyl-2-nitro-5-vinylimidazole.
Pelizza G; Nebuloni M; Ferrari P; Gallo GG; Pelizzi G; Tarasconi P
Farmaco Sci; 1978 Jan; 33(1):3-13. PubMed ID: 620774
[TBL] [Abstract][Full Text] [Related]
11. Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods.
Abu-Diak OA; Jones DS; Andrews GP
J Pharm Sci; 2012 Jan; 101(1):200-13. PubMed ID: 21905037
[TBL] [Abstract][Full Text] [Related]
12. [Crystalline polymorphism of eflucimibe].
Ribet JP; Pena R; Chauvet A; Patoiseau JF; Autin JM; Segonds R; Basquin M; Autret JM
Ann Pharm Fr; 2002 May; 60(3):177-86. PubMed ID: 12050596
[TBL] [Abstract][Full Text] [Related]
13. Structural characteristics and crystal polymorphism of three local anaesthetic bases crystal polymorphism of local anaesthetic drugs: part VII.
Schmidt AC
Int J Pharm; 2005 Jul; 298(1):186-97. PubMed ID: 15955643
[TBL] [Abstract][Full Text] [Related]
14. Enhanced dissolution of solid dispersions containing bicalutamide subjected to mechanical stress.
Szafraniec J; Antosik A; Knapik-Kowalczuk J; Chmiel K; Kurek M; Gawlak K; Paluch M; Jachowicz R
Int J Pharm; 2018 May; 542(1-2):18-26. PubMed ID: 29481948
[TBL] [Abstract][Full Text] [Related]
15. Nucleation and crystal growth in supersaturated solutions of a model drug.
Lindfors L; Forssén S; Westergren J; Olsson U
J Colloid Interface Sci; 2008 Sep; 325(2):404-13. PubMed ID: 18561941
[TBL] [Abstract][Full Text] [Related]
16. Box-Behnken study design for optimization of bicalutamide-loaded nanostructured lipid carrier: stability assessment.
Kudarha R; Dhas NL; Pandey A; Belgamwar VS; Ige PP
Pharm Dev Technol; 2015; 20(5):608-18. PubMed ID: 24785784
[TBL] [Abstract][Full Text] [Related]
17. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of a new polymorphic form and a solvate of glibenclamide.
Hassan MA; Sheikh Salem M; Sallam E; al-Hindawi MK
Acta Pharm Hung; 1997; 67(2-3):81-8. PubMed ID: 9223758
[TBL] [Abstract][Full Text] [Related]
19. Polymorphism of linezolid: a combined single-crystal, powder diffraction and NMR study.
Maccaroni E; Alberti E; Malpezzi L; Masciocchi N; Vladiskovic C
Int J Pharm; 2008 Mar; 351(1-2):144-51. PubMed ID: 17977677
[TBL] [Abstract][Full Text] [Related]
20. Improving the physicochemical properties of bicalutamide by complex formation with bovine serum albumin.
Yang C; Di P; Fu J; Xiong H; Jing Q; Ren G; Tang Y; Zheng W; Liu G; Ren F
Eur J Pharm Sci; 2017 Aug; 106():381-392. PubMed ID: 28571783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
